Literature DB >> 7292978

Primary adenocarcinomas of the human urinary bladder: histochemical, immunological and ultrastructural studies.

J Alroy, D Roganovic, B F Banner, J B Jacobs, F B Merk, A A Ucci, P W Kwan, J S Coon, A W Miller.   

Abstract

Neoplastic and non-neoplastic tissue specimens from ten patients with primary adenocarcinoma of the urinary bladder were examined. Most of these tumors were associated with either foci of transitional cell carcinoma and/or with glandular metaplasia of the bladder epithelium. The mucin produced by the neoplastic cells was PAS, alcian blue, mucicarmine, PB/KOH/PAS, and RPB/KOH/PAS-positive. ABH isoantigens of these tumors were not always deleted. Ultrastructurally, the neoplastic cells resembled goblet cells. Their plasma membrane had numerous microvilli with prominent glycocalyx. Proliferation and attenuation of tight junctions were noted. The gap junctions were few and small. Two types of desmosomes were found. The ultrastructural features of the neoplastic cells were attributed in part to the malignant transformation and in part to the direction of their differentiation. We have not observed any distinctive morphologic, histochemical, immunologic or ultrastructural features that might be diagnostic for these adenocarcinomas.

Entities:  

Mesh:

Year:  1981        PMID: 7292978     DOI: 10.1007/bf00431074

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histol        ISSN: 0340-1227


  51 in total

1.  Malignant transformation of urinary bladder in humans and in N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-exposed Fischer rats: ultrastructure of the major components of the permeability barrier.

Authors:  F B Merk; B U Pauli; J B Jacobs; J Alroy; G H Friedell; R S Weinstein
Journal:  Cancer Res       Date:  1977-08       Impact factor: 12.701

2.  Signet ring cell carcinoma of bladder.

Authors:  G E Austin; J Safford
Journal:  Urology       Date:  1978-10       Impact factor: 2.649

3.  Development of urinary bladder cancer in the rat.

Authors:  E Kunze
Journal:  Curr Top Pathol       Date:  1979

4.  A method for demonstrating blood group isoantigens in permanent tissue sections.

Authors:  J Alroy; K Temaura; I Davidsohn; R S Weinstein
Journal:  Stain Technol       Date:  1978-01

5.  A comparative electron microscopic study of human and rat colonic polyps and carcinomas.

Authors:  H J Spjut; M N Smith
Journal:  Exp Mol Pathol       Date:  1967-02       Impact factor: 3.362

6.  Alterations of intercellular junctions in acinic cell carcinoma of the canine pancreas.

Authors:  J Alroy; B F Banner; B U Pauli; I Leav
Journal:  Virchows Arch B Cell Pathol       Date:  1978-07-14

7.  Ultrastructural markers of colonic adenocarcinoma.

Authors:  W F Hickey; M W Seiler
Journal:  Cancer       Date:  1981-01-01       Impact factor: 6.860

8.  Isoantigens A, B and H in urinary bladder carcinomas following radiotherapy.

Authors:  J Alroy; K Teramura; A W Miller; B U Pauli; J E Gottesman; M Flanagan; I Davisohn; R S Weinstein
Journal:  Cancer       Date:  1978-05       Impact factor: 6.860

9.  Adenocarcinoma of the bladder as seen at Ochsner Medical Institutions.

Authors:  H A Fuselier; W Brannan; M G Ochsner; L H Matos
Journal:  South Med J       Date:  1978-07       Impact factor: 0.954

10.  Variability in the expression of the O(H) antigen in human transitional epithelium.

Authors:  J S Coon; R S Weinstein
Journal:  J Urol       Date:  1981-03       Impact factor: 7.450

View more
  2 in total

1.  Mucus-producing adenopapillary carcinoma of minor salivary gland origin with signet ring cells and intracytoplasmic lumina. A light and electron microscopic study.

Authors:  V C de Araújo; S O de Sousa; E A Lopes; N S de Araújo; A Sesso
Journal:  Arch Otorhinolaryngol       Date:  1988

2.  Multicystic urothelial carcinoma of the bladder with gland-like lumina and with signet-ring cells. A case report.

Authors:  Isabel Alvarado-Cabrero; Delia Pérez-Montiel; Ondrej Hes
Journal:  Diagn Pathol       Date:  2008-09-03       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.